Stay updated on RP1 in Solid Organ Transplant Patients Clinical Trial
Sign up to get notified when there's something new on the RP1 in Solid Organ Transplant Patients Clinical Trial page.
Latest updates to the RP1 in Solid Organ Transplant Patients Clinical Trial page
- Check2 days agoChange DetectedSponsor name formatting updated from Replimune Inc. to Replimune, Inc. The revision identifier changed from v3.5.0 to v3.5.2.SummaryDifference0.2%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNo additions or deletions detected between the two screenshots; the page content and layout look the same.SummaryDifference0.0%
- Check23 days agoChange DetectedAdded Cutaneous neuroendocrine carcinoma as a study keyword and included the Genetic and Rare Diseases Information Center as a resources reference.SummaryDifference0.1%
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This appears to be a minor metadata/version update that does not affect the study content or its purpose.SummaryDifference0.0%
- Check45 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No study content or critical information was changed.SummaryDifference0.0%
- Check52 days agoChange DetectedAdded ARTACUS study details for RP1 in solid organ transplant recipients with advanced skin cancers, including study design, endpoints, eligibility criteria, and participating sites. The previous ARTACUS entry was replaced with updated trial specifics, including revised conditions and investigator information.SummaryDifference5%
Stay in the know with updates to RP1 in Solid Organ Transplant Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP1 in Solid Organ Transplant Patients Clinical Trial page.